Vietnam Investment Review on MSN

PRISM BioLab and Receptor AI partner on drug discovery

TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...
Pharmaceutical Technology on MSN

PRISM BioLab partners with Receptor.AI for molecule discovery

The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.